Skip to content
Call Us Today! 1 (772) 595-9830 info@midwayresearch.com
Facebook
Twitter
LinkedIn
Instagram
Home
About
Clinical Trials
Currently Enrolling Studies
Active, not recruiting Studies
What is a Clinical Trial?
Expectations
Studies Phases
Informed Consent
Closed Studies
Services
HIV
STD
HPV
Lipodystrophy
Journal Publications
Contact
Home
About
Clinical Trials
Currently Enrolling Studies
Active, not recruiting Studies
What is a Clinical Trial?
Expectations
Studies Phases
Informed Consent
Closed Studies
Services
HIV
STD
HPV
Lipodystrophy
Journal Publications
Contact
Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects (ABL)
Home
/
Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects (ABL)
Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects (ABL)
midwayadmin
2019-10-28T19:34:34+00:00
Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects (ABL)
Frontier ABT-3BNC117201
·
Trial
·
Read more